Somatuline and bladder transitional cell carcinoma stage ii Patient Reports February 10, 2010

Somatuline Side Effects Report #5705615-6
Somatuline side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2008. Female patient, 71 years of age, was diagnosed with acromegaly and was treated with Somatuline. After drug was administered, patient experienced the following side effects: bladder transitional cell carcinoma stage ii, haematuria. Somatuline dosage: 120 MG EVERY 4 WEEKS INTRAMUSCULAR. During the same period patient was treated with ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.